After noticing unusual blood clotting in many patients diagnosed with COVID-19, doctors believe there may be a connection to the thickness of their blood, known as hyperviscosity, with inflammation and clotting. “IT HAS BEEN A MYSTERY WHY SO MANY PATIENTS WITH COVID-19 HAVE HAD ATYPICAL BLOOD CLOTS.” “It has been a mystery why so many...
Tag: <span>plasma therapy</span>
Teens can donate blood, but may need iron supplements after
by Alan Mozes, Healthday Reporter The concern comes as 16- to 18-year-olds have emerged as one of the fastest-growing groups of blood donors nationwide. But this study of nearly 31,000 teens who gave blood more than once between 2016 and 2018 found that roughly one in 10 were already iron-deficient when they donated for the...
Men’s blood contains greater concentrations of enzyme that helps COVID-19 infect cells
Evidence from a large study of several thousand patients shows that men have higher concentrations of angiotensin-converting enzyme 2 (ACE2) in their blood than women. Since ACE2 enables the coronavirus to infect healthy cells, this may help to explain why men are more vulnerable to COVID-19 than women. The study, published in the European Heart...
New blood test for Alzheimer’s developed
by Margareta G. Kubista, University of Gothenburg A new blood test for Alzheimer’s disease has been developed under the leadership of researchers at the University of Gothenburg. The method is based on measuring a specific variant of tau protein in ordinary blood samples, which makes the test relatively simple and cheap to perform. The research...
Johns Hopkins experts publish ‘guidebook’ for blood plasma therapy
“We’ve received many inquiries from health care providers looking to ramp up their ability to deliver this therapy,” says Evan M Bloch, M.D., M.S. an associate professor of pathology at the Johns Hopkins University School of Medicine who is part of the team working on convalescent therapy. “There is historical precedent for its use to...
Canadian clinical trial tests plasma therapy for COVID-19
by McMaster University Can those who survive COVID-19 provide blood to treat others hospitalized by the disease? That’s the question driving a Canadian consortium that has launched one of the world’s largest clinical trials of a potential treatment for COVID-19 —one that goes as far back as the Spanish flu a century ago. The treatment...